Research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research report issued on Tuesday. The firm set a “buy” rating on the stock.
Mannatech Stock Down 3.3 %
Shares of Mannatech stock opened at $10.84 on Tuesday. Mannatech has a 52-week low of $6.75 and a 52-week high of $15.83. The company has a 50 day moving average of $11.13 and a 200 day moving average of $8.79. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $20.37 million, a P/E ratio of -13.38 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The firm had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- How to Invest in the Best Canadian StocksÂ
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- 3 Stocks to Consider Buying in October
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Golden Cross Stocks: Pattern, Examples and Charts
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
